Prostate Active Surveillance Study
ConditionProstatic Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age21+
SponsorUniversity of Washington
About this trial
The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.
Eligibility criteria
Qualifiers
Histologically confirmed adenocarcinoma of the prostate from a prostate biopsy.
Clinically localized prostate cancer: T1-2, NX or N0, MX or M0.
No previous treatment for prostate cancer (including hormonal therapy, radiation therapy, surgery, or chemotherapy).
ECOG Performance Status 0 or 1.
Disqualifiers
Unwillingness or inability to undergo serial prostate biopsy.
History of other malignancies, except: adequately treated non-melanoma skin cancer or adequately treated superficial bladder cancer (Ta) or other solid tumors curatively treated with no evidence of disease for > 5 years.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
University of Washington
Lead sponsor
Canary Foundation
Collaborator
Early Detection Research Network
Collaborator
Source ClinicalTrials.gov